Abstract:Lu Chen, 1, &ast Yu Zhong, 2, &ast Yong-Sheng Li, 3 He Zhuang, 4 Xin Li, 5 Sheng-Ping Liu, 5 Jing-Gang Li, 5 Qiu Lin, 4 Fei Gao 5 1 Department of Paediatrics, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350000, People's Republic of China; 2 Department of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, 350122, People's Republic of China; 3 Department of Urology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 4 Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China; 5 Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, 350001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Gao, Email Background: Accurate, sensitive, and rapid identification of leukemia cells in blood and bone marrow is of paramount significance for clinical diagnosis. An integrative technique combining traditional cytomorphology with immunophenotyping was proposed to improve the diagnostic efficiency in leukemia. On account of high photostability, biocompatibility, and signal-to-background ratio, upconversion nanoparticles (UCNPs) as luminescent labels have drawn substantial research scrutiny in immunolabeling. Methods: To achieve simultaneous determination, NaYF 4 :Yb,Er UCNPs were coupled with CD38 antibodies to construct immunofluorescence probes that were developed to bind to diffuse large B cell lymphoma (DLBCL) cells, followed by Wright's staining that has been widely used in clinical work for morphological diagnosis. Further, the experimental conditions were optimized, such as medium, slice-making method, antibody dosage, incubation time, etc. Results: The cell morphology and immunolabeling could be observed simultaneously, and its simple operation rendered it a possibility for clinical diagnosis. The developed immunolabeling assay could achieve DLBCL cell counting with high reproducibility and stability, and the detection limit was as low as 1.54 cell/slice (> 3 σ/s). Moreover, the proposed method also realized real blood and bone marrow sample analysis, and the results were consistent with the clinical diagnosis. Conclusion: Overall, this strategy can be carried out after simple laboratory training and has prospective biomedical applications in leukemia classification, diagnosis validation, and differential diagnostics. Graphical Keywords: leukemia, upconversion nanoparticle, immunofluorescence probe, Wright's staining, cytomorphology Graphical Leukemia, a generic term, encompasses several life threatening malignant disorders that present with incremental amounts of leucocytes in blood and bone marrow. Leukemia cells have the innate ability for migration and invasion. 1 Dedifferentiated and malignant leucocytes not only retain the benign leucocytes capacity for cell motility and survival in the circulation, but obtain the potential for rapid and uncontrolled cell division. 1 Accordingly, leukemia is aggressive and is a challenging disease to treat. Regrettably, leukemia may occur at all ages from the newborn to the aged with different forms and various age distributions. 2 Rapid and accurate diagnosis of leukemia is vital to prevent disease progression and reduce mortality. Currently, the common diagnostic techniques toward leukemia principally lean on cytomorphology, cytochemistry, immunophenotyping (flow cytometry, FCM), cytogenetics (chromosome analysis and fluorescence in situ hybridization), and molecular genetics (polymerase chain reaction and sequencing technique). 3–5 Regrettably, there is a shortage of FCM equipment, and other cytogenetics and molecular genetics methods available at laboratory diagnostic centers require expensive equipment, experienced personnel, immediate processing, tedious operation, and so on. 6,7 Correspondingly, cytomorphology is an indispensable approach in hematological disease diagnosis owing to its fast evaluation of specimens, thus endowing time-saving and cost-effective characteristics. Specifically, trained hematologists can distinguish abnormalities in cell morphology or potential leukemia cells from normal counterparts. 8 Further, assessment of the percentage and relative distribution of erythropoiesis, granulopoiesis, and monocytopoiesis can identif -Abstract Truncated-

Raman and quantitative phase imaging allow morpho-molecular recognition of malignancy and stages of B-cell acute lymphoblastic leukemia

Identification and Staging of B-Cell Acute Lymphoblastic Leukemia Using Quantitative Phase Imaging and Machine Learning

Advancing triage of acute lymphoblastic leukaemia subtypes diagnosis: label-free Raman spectroscopy for precise single-cell phenotyping and subtype classification

Raman Spectroscopy Differ Leukemic Cells from Their Healthy Counterparts and Screen Biomarkers in Acute Leukemia

Label-free, rapid and highly accurate identification and categorization of leukemia cells via Raman spectroscopy

Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy

Spontaneous-stimulated Raman co-localization dual-modal analysis approach for efficient identification of tumor cells

Recognition of Nucleophosmin Mutant Gene Expression of Leukemia Cells Using Raman Spectroscopy

High-resolution Raman imaging of >300 cells from human patients affected by nine different leukemia subtypes: a global clustering approach

High-resolution Raman imaging of >300 patient-derived cells from nine different leukemia subtypes: a global clustering approach

Intelligent Dual-Modality Label-Free Cell Classification with Light Scattering Imaging and Raman Spectra Measurements

Immunophenotyping of 222 Children with Acute Leukemia by Multi-Color Flow Cytometry

Label-Free Identification of AML1-ETO Positive Acute Myeloid Leukemia Using Single-Cell Raman Spectroscopy

Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia

Clinically Useful Flow Cytometry Approach to Identify Immunophenotype in Acute Leukemia

A Novel and Rapid Smear Cytomorphology Detection Strategy Based on Upconversion Nanoparticles Immunolabeling Integrated with Wright's Staining for Accurate Diagnosis of Leukemia

Combining array-assisted SERS microfluidic chips and machine learning algorithms for clinical leukemia phenotyping

Low coherence quantitative phase microscopy with machine learning model and Raman spectroscopy for the study of breast cancer cells and their classification

Optical Tweezers and Raman Spectroscopy for Single-Cell Classification of Drug Resistance in Acute Lymphoblastic Leukemia.

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia